Frontier Airlines has managed to snap a four-year full-year net loss streak, ending the year with a net profit of $85 million, with the airline’s chief executive praising its revenue and network ...

Neurocrine stock took a hit late Thursday after the biotech company issued a light 2025 outlook for its drug, Ingrezza.

Frontier Group Holdings, Inc. (Nasdaq: ULCC ), parent company of Frontier Airlines, Inc., today reported financial resul ...

We collect and process your personal information for the following purposes: Authentication, Preferences, Acknowledgement and Statistics. To learn more, please read our privacy policy.